Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.86 |
| ▸ | CHAT | P28329 | 2/20 | 0.82 |
| ▸ | EP300 | Q09472 | 4/20 | 0.81 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.81 |
| ▸ | AURKA | O14965 | 2/20 | 0.81 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.81 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL168546 | 1.00 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20815900 | 1.00 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL14992960 | 0.97 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL23924590 | 0.97 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL30221076 | 0.97 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20815901 | 0.96 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL31099171 | 0.96 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20524261 | 0.95 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL1404073 | 0.95 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL17276002 | 0.95 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163478-A1 | BIOCONVERSION OF LEVULINIC ACID IN GENETICALLY ENGINEERED HOSTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-05-22 | — | — | US | disclosed |
| US-12116609-B2 | Bioconversion of levulinic acid in genetically engineered hosts | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2024-10-15 | — | — | US | disclosed |